Quidel | QDEL - Ordinary Share Capital


Quidel reported $67.9M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.7M 358K Dec/2025
Avanos Medical USD 46.46M 39.46K Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bruker USD 151.94M 225K Dec/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Danaher USD 706.9M 600K Dec/2025
Exact Sciences USD 189.45M 232K Sep/2025
Haemonetics USD 46.83M 82K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Illumina USD 152.8M 900K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Myriad Genetics USD 93.1M 0 Sep/2025
Neogen USD 217.53M 227K Sep/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 67.9M 200K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
STAAR Surgical USD 49.4M 49K Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Waters USD 98.08M 38.55M Dec/2025